141 related articles for article (PubMed ID: 38406105)
1. Unusual Presentation of a Hepatic Neuroendocrine Tumor With Elevated CEA and CA 19-9: A Case Report.
Zolotov E; Sigal A; Hazaveh S; Patel V; Zhu H
Cureus; 2024 Jan; 16(1):e52858. PubMed ID: 38406105
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms.
Gao C; Fan Z; Yang J; Shi M; Li Y; Zhan H
Pancreatology; 2023 Mar; 23(2):204-212. PubMed ID: 36710224
[TBL] [Abstract][Full Text] [Related]
3. [The pre- and postoperative monitoring of the immunological indices and tumor markers in colorectal carcinoma].
Iarŭmov N; Ignatov A; Viiachki I
Khirurgiia (Sofiia); 1998; 51(3):42-8. PubMed ID: 9974027
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up.
Rahmani F; Tohidi M; Azmoudeh-Ardalan F; Sadeghi A; Hadaegh F
BMC Endocr Disord; 2023 Aug; 23(1):186. PubMed ID: 37649029
[TBL] [Abstract][Full Text] [Related]
5. [A Case of Extrahepatic Bile Duct Carcinoid Tumor Involving Diagnostic Difficulties].
Yabe N; Masuda M; Tamura E; Morishige S; Saito A; Harada Y; Miyabayashi M; Kobayashi K; Iwama N; Takenoya T; Oto I; Yoshikawa T; Osumi K; Murai S
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2024-2026. PubMed ID: 32157047
[TBL] [Abstract][Full Text] [Related]
6. Clear cell neuroendocrine tumor in the gallbladder diagnosed as a benign polyp preoperatively: a case report.
Sumiya R; Shimizu A; Nagai T; Ono H; Kumazawa K; Endo D; Oide T; Aoyanagi N
World J Surg Oncol; 2021 Jan; 19(1):3. PubMed ID: 33388069
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine tumor of the common bile duct: case report.
Raspanti C; Falco N; Silvestri V; Rotolo G; Bonventre S; Gulotta G
G Chir; 2016; 37(6):275-280. PubMed ID: 28350976
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies.
Frenette PS; Thirlwell MP; Trudeau M; Thomson DM; Joseph L; Shuster JS
Tumour Biol; 1994; 15(5):247-54. PubMed ID: 7991985
[TBL] [Abstract][Full Text] [Related]
9. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Haglund C
Anticancer Res; 2002; 22(4):2311-6. PubMed ID: 12174919
[TBL] [Abstract][Full Text] [Related]
10. Significance of serum tumor markers carcinoembryonic antigen, CA 19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation.
Pissaia A; Bernard D; Scatton O; Soubrane O; Conti F; Calmus Y
Transplant Proc; 2009 Mar; 41(2):682-4. PubMed ID: 19328956
[TBL] [Abstract][Full Text] [Related]
11. Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma.
Vukobrat-Bijedic Z; Husic-Selimovic A; Sofic A; Bijedic N; Bjelogrlic I; Gogov B; Mehmedovic A
Med Arch; 2013 Dec; 67(6):397-401. PubMed ID: 25568506
[TBL] [Abstract][Full Text] [Related]
12. CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy.
Lee DW; Im SA; Kim YJ; Yang Y; Rhee J; Na II; Lee KH; Kim TY; Han SW; Choi IS; Oh DY; Kim JH; Kim TY; Bang YJ
Cancer Res Treat; 2017 Jul; 49(3):807-815. PubMed ID: 28111425
[TBL] [Abstract][Full Text] [Related]
13. Increased serum carbohydrate antigen 19-9 in relapsed ductal breast carcinoma.
Papantoniou V; Tsiouris S; Koutsikos J; Ptohis N; Lazaris D; Zerva C
Hell J Nucl Med; 2006; 9(1):36-8. PubMed ID: 16617392
[TBL] [Abstract][Full Text] [Related]
14. A Case of Distal Common Bile Duct Obstruction Due to a Neuroendocrine Tumor.
Rayes R; Partovi O; Strohbeen S; Bureau BL; Giorgadze T; Mostafa M; Asmi N
Cureus; 2024 Jan; 16(1):e52729. PubMed ID: 38384597
[TBL] [Abstract][Full Text] [Related]
15. Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix.
Carmignani CP; Hampton R; Sugarbaker CE; Chang D; Sugarbaker PH
J Surg Oncol; 2004 Sep; 87(4):162-6. PubMed ID: 15334630
[TBL] [Abstract][Full Text] [Related]
16. Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies.
Brockmann J; Emparan C; Hernandez CA; Sulkowski U; Dietl KH; Menzel J; Wolters H; Glodny B; Senninger N
Anticancer Res; 2000; 20(6D):4941-7. PubMed ID: 11326643
[TBL] [Abstract][Full Text] [Related]
17. The Significance of Serum Tumor Markers CEA, Ca 19-9, Ca 125, Ca 15-3, and AFP in Patients Scheduled for Orthotopic Liver Transplantation: Do Elevated Levels Really Mean Malignancy?
Baskiran DY; Sarigoz T; Baskiran A; Yilmaz S
J Gastrointest Cancer; 2023 Jun; 54(2):442-446. PubMed ID: 35312953
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A longitudinal study.
Guadagni F; Roselli M; Amato T; Cosimelli M; Mannella E; Perri P; Abbolito MR; Cavaliere R; Colcher D; Greiner JW
Cancer; 1991 Dec; 68(11):2443-50. PubMed ID: 1933781
[TBL] [Abstract][Full Text] [Related]
19. Mucinous biliary cystadenoma with mesenchymal stroma: expressions of CA 19-9 and carcinoembryonic antigen in serum and cystic fluid.
Lee JH; Chen DR; Pang SC; Lai YS
J Gastroenterol; 1996 Oct; 31(5):732-6. PubMed ID: 8887044
[TBL] [Abstract][Full Text] [Related]
20. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
